Rationale δ9-tetrahydrocannabinol (δ9- THC) modifies dopamine efflux. However, the extent to which cannabinoid and dopamine drugs modify each other's behavioral effects has not been fully established. Objectives This study examined dopamine releasers and/or transport inhibitors alone and in combination with cannabinoids in two drug discrimination assays. Methods Experimentally and pharmacologically experienced rhesus monkeys (n05) discriminated δ9-THC (0.1 mg/kg i.v.) from vehicle while responding under a fixed ratio 5 schedule of stimulus-shock termination. A separate group (n06) of monkeys responded under the same schedule, received daily δ9-THC (1 mg/kg/12 hs.c.), and discriminated the cannabinoid antagonist rimonabant (1 mg/kg i.v.), i.e., cannabinoid withdrawal, from vehicle. A sign of withdrawal sign (head shaking) was examined in monkeys receiving δ9-THC daily. Results Rimonabant antagonized the δ9-THC discriminative stimulus and a dose of δ9-THC greater than the daily treatment attenuated the rimonabant discriminative stimulus. In monkeys discriminating δ9-THC, the dopamine transporter ligands cocaine, amphetamine, bupropion, RTI 113, and RTI 177 produced a maximum of 2% responding on the drug lever and blocked the discriminative stimulus effects of δ9- THC. In δ9-THC treated monkeys discriminating rimonabant, the dopamine transporter ligands partially substituted for and increased the potency of rimonabant to produce discriminative stimulus effects. The dopamine antagonist haloperidol enhanced the δ9-THC discriminative stimulus without significantly modifying the rimonabant discriminative stimulus. Imipramine and desipramine, which have low affinity for dopamine transporters, were less effective in modifying either the δ9-THC or rimonabant discriminations. The dopamine transporter ligands and haloperidol attenuated head shaking, whereas imipramine and desipramine did not. Conclusions Dopamine release and/or inhibition of dopamine transport blocks detection of δ9-THC and is potentially the mechanism by which some therapeutics (e.g., bupropion) reduce the subjective effects of marijuana and enhance the subjective effects of marijuana withdrawal.
|Original language||English (US)|
|Number of pages||14|
|State||Published - Aug 2012|
- Drug discrimination
ASJC Scopus subject areas